Skip to main content
. 2019 Sep 22;11(10):1414. doi: 10.3390/cancers11101414

Figure 4.

Figure 4

Serum MMP-2 (A) and MMP-9 (B) concentrations by treatment group (median, IQR and range) measured from samples at 14 days post-primary tumour excision (n = 12 animals per group). * indicates significant difference compared to group S (p < 0.05). • indicates outliers by Tukey’s method (>1.5 × IQR). Abbreviations: S, sevoflurane alone; S + L, sevoflurane and lidocaine; S + B, sevoflurane and bosutinib; S + B + L, sevoflurane, lidocaine and bosutinib.